Gladstone NOW: The Campaign Join Us on the Journey✕
226 - 240 of 251 Results Clear All
WebMD—Scientists urge that testing be completed on drugs, such as chloroquine or hydroxychloroquine, before being used on patients, to prevent possible negative and unintended effects.
Communications COVID-19 Center for HIV Cure Research Virology Greene Lab
ABC7 News—While some COVID-19 cases are severe and cause rapid decline, other patients experience only mild symptoms. Gladstone President Deepak Srivastava explains how stem cell research could help explain this phenomenon, and lead to targeted treatments.
Research (Publication) COVID-19 Stem Cells/iPSCs
STAT News—Gladstone Investigator Melanie Ott describes what’s necessary to set up a biosafety level 3 lab (BSL-3) for research on live coronavirus.
Gladstone Experts Research (Publication) COVID-19 Ott Lab
Nikkei Asian Review—Gladstone Senior Investigator Nevan Krogan describes how his lab launched a collaborative effort to map all human proteins that interact with SARS-CoV-2, the virus that causes COVID-19. Through this heroic effort, a map was produced in just a few weeks. Now, the team is testing to see if drugs can be used to disrupt those interactions to fight the infection.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab
The Atlantic—The coronavirus has only 29 proteins. How is it possible that so few amounts can wreak havoc with the tens of thousands of healthy proteins in our bodies?
Communications COVID-19 Virology Ott Lab
The Stem Cell Podcast—Gladstone President Deepak Srivastava describes his work using human induced pluripotent stem cells to investigate the gene networks that dictate cell fate decisions, and how this research could lead to therapeutics for congenital heart disease and heart failure. He also describes the importance of stem cell research in fighting the COVID-19 pandemic.
Gladstone Experts COVID-19 Heart Failure Congenital Heart Disease Cardiovascular Disease Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs
Chemical and Engineering News (C&EN)—Will convalescent plasma, the antibody-rich portion of blood donated from someone who recovered from the disease, be the answer to helping patients that are sick with the coronavirus? History may repeat itself, as this was one solution used to combat the Spanish flu of 1918.
Communications COVID-19 Virology Greene Lab
The Scientist—Gladstone researchers quickly pivot to work to get SARS-CoV-2 research up and running. The Ott Lab is relying on previously established lung organoids to test the effects of the virus.
Communications COVID-19 Virology Ott Lab
San Francisco Chronicle—As Bay Area residents emerge from the coronavirus pandemic, how will life moving forward be different? Distancing, face masks, and hand sanitizer could be part of our future for a long time.
Communications COVID-19 Virology Greene Lab
San Francisco Chronicle—Scientists believe that asymptomatic transmission is driving the pandemic. The unintentional passing of a virus from an infected person is what lead California, including the Bay Area, to advise using masks when heading into a public space.
Communications COVID-19 Virology Greene Lab
Learn more about opportunities to support Gladstone's COVID-19 research.
COVID-19 Virology
Watch a special webinar hosted by Gladstone and Give2Asia that discusses the importance of collaboration during the COVID-19 outbreak.
Gladstone Experts COVID-19 Virology Ott Lab
You can help advance research on COVID-19
News Release Bioinformatics Core COVID-19 Data Science and Biotechnology Pico
Using coronavirus proteins as baits, researchers led by Gladstone Senior Investigator Nevan Krogan identified human proteins that may mediate infection and become targets for new therapies.
Research (Publication) COVID-19 Virology Krogan Lab
In keeping with our commitment to science overcoming disease, Gladstone will open a highly secured laboratory for research on live coronavirus.
Gladstone Experts Institutional News Research (Publication) COVID-19 Virology Ott Lab
